You may also like
COVID-19: Myocardial Injury in Survivors
In summary, myocardial injury is common in hospitalized COVID-19 patients and not exclusive to those with ACS or PE. In this single-centre, single-timepoint convalescent study, myocardial injury was associated with cardiac abnormalities detected by CMR where troponin elevation is unexplained even when cardiac function is normal.
Perfusion Partners Settles Patent Dispute With Cytomedix
Cytomedix (AMEX:GTF - News) today announced that Perfusion Partners and Associates Inc. (PPAI), based in Fort Meyers, Florida, and its affiliate organization, Transcorporeal Inc., have settled a patent dispute with Cytomedix for its platelet-derived therapies for treating wounds and other damaged tissue.
Role of Platelet-Rich Plasma in Soft Tissue Root-Coverage Procedures: A Review
The aim of this article was to review the current evidence on the role of platelet-rich plasma (PRP) in enhancing root-coverage techniques and discuss the rationale for its use in these applications.
